Research Article

S100A4 May Be a Good Prognostic Marker and a Therapeutic Target for Colon Cancer

Table 1

The Association between the S100A4 expression status, the staining status of the tumor tissue, and clinicopathologic variables.
(a) S100A4 expression.

Clinicopathologic featuresVariablesAbsentPresentTotalChi-square Test
n%n%n%p

TNM StageI531.364.6117.40.001
II956.35541.76443.2
III003828.83825.7
IV212.533253523.7

Duration of Survival< 2 years531.3957210067.60.003
2-5 years318.31712.92013.5
5-10 years8502015.22818.9

(b) Distribution of tumor tissue staining.

Clinicopathologic featuresVariablesAbsentSuperficialDeepCompleteTotalChi-square Test
n%n%n%n%n%p

Age Groups< 60 years 42522551066.72836.46443.20.026
> 60 years 12751845533.34963.68456.8

Colon-Tumor LocalizationRight956.32357.5533.33748.174 500.003
Transverse00512.53201823.42617.6
Left 4257 17.516.710 132214.9
Sigmoid0037.500 911.7128.11
Multicentric318.625640 3 3.9149.46

TNM StageI531.341000 2 2.6117.430.001
II956.32562.5853.32228.66443.2
III004103203140.33825.7
IV212.5717.5426.72228.63523.65

Duration of Survival< 2 years531.32870853.35976.610067.60.002
2-5 years318.825426.71114.32013.5
5-10 years8501025320 79.092818.9